The Latest Cardiac and Vascular News
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2018 will be released before market open on Thursday, May 3, 2018. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, May 3, 2018. The call can be accessed through a […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, manufacturers of laser-based solutions for the treatment of cardiovascular and dermatological diseases, announced today that the Company has appointed Andrew Jackson as its Chief Financial Officer, effective immediately. Mr. Jackson has over 20 years of finance experience in life science and technology companies, including extensive […]
MILWAUKEE–(BUSINESS WIRE)–APN Health, LLC (www.apnhealth.com) announces its Navik 3D mapping system is commercially released and in clinical use. The first clinical case using the technology was performed on March 22nd at St. Luke’s Medical center in Milwaukee. Navik 3D is intended for catheter-based atrial and ventricular mapping using compatible catheters […]
ALAMEDA, Calif., April 18, 2018 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2018 after market close on Tuesday, May 8, 2018 at 4:30 PM Eastern Time. A press release with first quarter 2018 financial results will be issued after market […]
ZWICKAU, Germany, April 18, 2018 /PRNewswire/ — HeartStitch® has received its CE Mark in the European Union for its device for treatment of mitral valve repair. This approval will provide physicians the ability to remodel the leaflets of the mitral valve and reestablish proper coaptation. The CoAp Pro expands HeartStitch’s product line of cardiovascular […]
SANTA CRUZ, Calif., April 19, 2018 /PRNewswire/ — Emboline, Inc., an emerging medical device company with a game-changing device for total embolic protection during transcatheter aortic valve replacement (TAVR) procedures, announced today that it has completed a Series B funding round totaling over $10 million. The funding includes $3 million in new […]
SEATTLE, April 19, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it has been recognized as one of the Top 10 Cardio Vascular Device Companies of 2018 by MedTech Outlook Magazine, an industry periodical committed to covering the […]
ATLANTA, April 17, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 first quarter financial results will be released on Wednesday, May 2, 2018 after the market closes. On Thursday, May 3, 2018 the Company will hold a teleconference call and live webcast at 8:00 […]
ABBOTT PARK, Ill., April 18, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2018. First-quarter worldwide sales of $7.4 billion increased 16.7 percent on a reported basis and 6.9 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.23 in the first quarter. Adjusted diluted EPS from […]
VANCOUVER, April 17, 2018 /PRNewswire/ – Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced completion of enrollment for the Phase 4 SPECTRUM study evaluating Brinavess® (vernakalant hydrochloride, IV), the Company’s antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF), in the post-authorization […]
